Skip to content

Clinical trials

Completed Phase 1 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 1 Status: Completed Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20053
20063
20071
20082
20092
20105
20115
20127
20135
20144
20151
20164
20172
20183
20192
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
H. Lee Moffitt Cancer Center and Research Institute4
Novartis Pharmaceuticals3
Genzyme, a Sanofi Company2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
University of Pennsylvania2
AO GENERIUM1
Advaxis, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma58
Neoplasms21
Pancreatic Neoplasms17
Carcinoma, Non-Small-Cell Lung11
Colorectal Neoplasms9
Neoplasm Metastasis9
Breast Neoplasms8
Lung Neoplasms7
Carcinoma5
Melanoma5

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.